MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00618917 · TERMINATED

Trial details

NCT number: NCT00618917
Sponsor: Joel Greenberger
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Esophageal Toxicity

Start date: 2005-11-11
Primary completion: 2010-02-26
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.